United States · FDA National Drug Code directory
QAMZOVA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82972-001_56c50daa-5791-226d-e063-6294a90a4787
- Product NDC
- 82972-001
- Form
- INJECTION
- Composition / generic term
- Meloxicam
- Labeler
- Nanjing Delova Biotech Co., Ltd.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251015
- Source listing expiry
- 20271231
Source-listed ingredients
- MELOXICAM — 30 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (82972-001-30) / 1 mL in 1 VIAL, SINGLE-DOSE · 82972-001-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →